BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.0090
0.00%
(0.00) 1D
Nov 11, 4:10:09 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
24.86M
Avg. vol.
10.54M
Volume
11.23M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
24.86M
Avg. vol.
10.54M
Volume
11.23M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
FOREX.com
·
48 minutes ago
S&P 500 forecast: tech rebound faces CPI test | Technical Tuesday
BigGo Finance
·
2 hours ago
UBS Sees S&P 500 at 8,900 by End-2027 as BofA Flags Crowded Index Trade
Eurasia Business News
·
4 hours ago
Stock Market Today: Dow Jones, Nasdaq, S&P 500 Fall on November 10, 2026; Oil and Gold Retreat
The Motley Fool
·
3 hours ago
S&P 500 Sell-Off: 1 Investing Step to Take Right Now, and 1 Risky Move to Avoid
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com